Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Hyperuricemia and Hypertension: Links and Risks
Douglas J Stewart1, Valerie Langlois1,2, Damien Noone1,2
1Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Insights
High uric acid levels (hyperuricemia) are linked to cardiovascular risks, especially hypertension in adolescents. More research is needed to confirm causality and the effectiveness of uric acid-lowering therapies.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Metabolic Disorders
Background:
- Hyperuricemia is associated with increased cardiovascular risk, particularly hypertension.
- This link appears stronger in pediatric populations.
- Uric acid's dual role as an extracellular antioxidant and intracellular pro-inflammatory agent contributes to microvascular injury.
Purpose of the Study:
- To review current data on the relationship between hyperuricemia and hypertension.
- To highlight the need for robust prospective studies.
- To assess the current evidence for uric acid-lowering therapies in hypertension prevention.
Main Methods:
- Review of existing epidemiological and clinical studies.
- Analysis of proposed mechanisms linking uric acid to hypertension.
- Identification of research gaps and limitations.
Main Results:
- Chronic hyperuricemia may lead to microvascular injury and afferent arteriolopathy, contributing to resistant hypertension.
- Establishing direct causality is challenging due to confounding factors like body mass index.
- Current evidence supporting uric acid-lowering therapies for hypertension risk mitigation is limited.
Conclusions:
- Further large-scale prospective randomized controlled trials are essential to establish causality and therapeutic efficacy.
- The role of hyperuricemia in hypertension requires more definitive investigation.
- Current data does not strongly support using uric acid-lowering therapies to prevent hypertension.
Abstract:
Hyperuricemia has long been recognized to be associated with increased cardiovascular risk, including risk of developing hypertension. Epidemiological findings suggest that the link with hypertension is stronger in children and adolescents. Uric acid acts as a strong antioxidant compound in the extracellular environment but has pro-inflammatory effects within the intracellular setting. A chronic phase of microvascular injury is known to occur after prolonged periods of hyperuricemia. This is proposed to contribute to afferent arteriolopathy and elevation of blood pressure that may become unresponsive to uric acid-lowering therapies over time. Studies have struggled to infer direct causality of hyperuricemia due to a vast number of confounders including body mass index. The aim of this review is to present the available data and highlight the need for large scale prospective randomized controlled trials in this area. At present, there is limited evidence to support a role for uric acid-lowering therapies in helping mitigate the risk of hypertension.
More Related Videos
10:02Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
Published on: October 3, 2020
07:52A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Antihypertensive Drugs: Action of Diuretics
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Urinary Tract Calculi IV: Nutrition Therapy and Prevention